Nephrology Doctors in Melbourne, FL Accepting Medicare

8 Nephrology doctors found. Showing 1 - 8

Wayne D Rodriguez, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2g, Melbourne, FL 32901 Phone: 321-549-0528    Fax: 321-722-3843

Peter J Gilbert, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-725-4500    Fax: 321-722-3843

Dr. Tamer S. Ahmed, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 111 E Hibiscus Blvd, Melbourne, FL 32901 Phone: 321-768-3655    Fax: 321-831-3024

Dr. Anthony H Tran, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 111 E Hibiscus Blvd, Melbourne, FL 32901 Phone: 321-768-3655    Fax: 321-831-3024

Rhodes M Kriete, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-725-4500    Fax: 321-722-3843

Claus Peter Spies, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2g, Melbourne, FL 32901 Phone: 321-549-0533    Fax: 321-722-3843

Dr. Disha Trivedi, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 111 E Hibiscus Blvd, Melbourne, FL 32901 Phone: 321-768-3655    Fax: 321-831-3024

Dr. Chirag Faldu, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-725-4500    Fax: 321-722-3843

News Archive

Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations

Colorectal Cancer has now become one of the leading causes of death. Studies indicate that smoking, low physical activities and high-fat diet are a major risk factor for colorectal cancer.

Study looks at health care in 21 countries

A new study involving health care systems in 21 countries - and the prospects for change in response to such common pressures as rising costs and aging populations - casts doubt on the possibility of major overhauls of any of these systems because of the history and traditions that created them.

Optimer reports grant of inducement stock options

Optimer Pharmaceuticals, Inc. announced today that on March 31, 2011 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 258,000 shares of common stock to 7 new employees.

Low-risk thyroid cancer and stringent follow-up: who decides?

In the case of low-risk treated thyroid cancer, some patients may be insisting on unduly intensive surveillance in the form of diagnostic scans to detect recurrence, without clear evidence for any benefit from the same, says a new study published in the Journal of Clinical Oncology.

Two pharma companies plan international trials into targeted cancer treatments in the UK

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

Read more Medical News

› Verified 1 days ago